Hyphema is a health condition defined by the presence of blood in the front chamber of the eye, known as the area between the clear front part of the eye (cornea) and the colored part of the eye (iris). Usually, it is triggered by damage or harm to the eye, though it may also be linked to specific hidden medical disorders.
When the eye experiences a blunt or penetrating injury, blood vessels in the iris or other parts of the eye may rupture, leading to bleeding into the anterior chamber. The severity of hyphema can vary, ranging from a small amount of blood that partially fills the chamber to a complete filling of blood, obstructing vision.
Epidemiology
The epidemiology of Hyphema:
Incidence and Prevalence: Hyphema is a rare condition, but it can happen among diverse demographics and age brackets. The occurrence and frequency of Hyphema fluctuate based on variables like geographical location, age, and the existence of risk factors. The documented incidence rates 12 out of 100 000, with 70% occurring in children.
Age and Sex: Hyphema can occur at any age, but it is more frequently observed in certain age groups. In children and adolescents, Hyphema commonly occurs due to sports-related injuries. Males are more commonly affected by Hyphema than females, particularly in younger age groups.
Geographical distribution: There may be variations in the incidence and prevalence of Hyphema across different regions or populations. Research indicates that urban settings have a higher prevalence of Hyphema than rural areas, which may be attributed to greater engagement in activities that pose a risk of eye injury.
Anatomy
Pathophysiology
The pathophysiology of Hyphema involves the disruption of blood vessels within the eye, leading to bleeding into the anterior chamber.
Trauma or injury: Hyphema is frequently caused by vascular damage to the eye. The iris, ciliary body, or other areas of the eye may suffer damage to their blood vessels as a result of blunt or penetrating trauma.
Blood accumulation: When blood flows into the front part of the eye, it builds up and occupies the area between the cornea and iris. The buildup of blood can range from a thin layer to entirely blocking eyesight, depending on the amount of bleeding.
Disruption of normal ocular structures: The presence of blood in the anterior chamber can disrupt normal ocular structures and physiological processes. The blood may interfere with the passage of light, leading to blurred or decreased vision.
Vascular rupture: The damage to the eye’s anterior segment results in the rupture of blood vessels, causing blood to spill into the anterior chamber. The severity of the bleeding is determined by the extent and intensity of the injury.
Etiology
Trauma: Trauma to the eye is the most common cause of Hyphema. It can result from various activities or accidents such as sports-related injuries, automobile accidents, falls, or physical assaults.
Tumors or Vascular Abnormalities: Hyphema can be associated with ocular tumors or vascular abnormalities. Conditions such as iris melanoma or vascular malformations may present with Hyphema.
Ocular Surgeries: In certain instances, Hyphema may arise as a complication of surgical interventions or procedures related to the eyes. Such interventions may encompass intraocular surgeries such as cataract surgery, glaucoma surgery, or refractive surgery.
Genetics
Prognostic Factors
The key prognostic factors in Hyphema as follows:
Size and extent: The magnitude and range of blood in the front chamber are crucial predictive factors. Larger Hyphema, where the front chamber is more broadly filled with blood, may carry a greater risk of complications and inferior results compared to smaller Hyphema.
Timing of treatment: The time elapsed between the occurrence of trauma and presentation for medical evaluation can influence prognosis.
Intraocular pressure (IOP) elevation:Elevated intraocular pressure following Hyphema can lead to a condition called Hyphema-induced glaucoma.
Rebleeding: Recurrence of bleeding in the front part of the eye after the first occurrence of Hyphema is known as rebleeding. This can raise the chances of complications and may suggest more serious underlying harm or continuous trauma.
Clinical History
CLINICAL HISTORY
Age Group: Hyphema can occur at any age, but the age group most affected by Hyphema varies based on the underlying cause.
Pediatric age group: Hyphema is a commonly observed condition in children and teenagers, which is often caused by injuries sustained during sports activities. Sports like basketball, soccer, baseball, martial arts, or any other sport that may result in eye trauma can cause Hyphema.
Young Adults: Young adults who engage in sports, high-risk occupations, or activities with potential eye injuries are also at an increased risk of Hyphema.
Physical Examination
PHYSICAL EXAMINATION
External Examination: Inspect the external structures of the eye for any signs of trauma, such as eyelid lacerations, swelling, or bruising.
Evaluation and magnitude of Hyphema: Evaluate the quantity of blood in the front part of the eye. It could vary from a slight accumulation at the base to a complete filling of the chamber.
Dilated Fundus Examination: Perform a dilated fundus examination to evaluate the posterior segment of the eye, including the optic nerve, retina, and macula.
Coagulation occurrence: Monitor the presence of blood clots in the Hyphema that might need additional treatment.
Iridodialysis or angle recession: Inspect for any indications of harm to the iris or angle, which can happen in severe injury cases.
Age group
Associated comorbidity
Associated Comorbidity or Activity:
Some of the commonly observed comorbidities in Hyphema include:
Ocular Conditions: Bleeding in the eye can result in elevated pressure inside the eye, which could trigger or exacerbate glaucoma in certain situations. Those who already have glaucoma may have an increased likelihood of experiencing bleeding in the eye due to weakened blood flow and delicate vessels.
Specific conditions affecting the retina, like diabetic retinopathy or retinal detachment, may heighten the possibility of bleeding in the front part of the eye and consequent eye bleeding.
Systemic Conditions: Uncontrolled high blood pressure can weaken blood vessels in the eye, making them more susceptible to rupture and bleeding. Individuals with sickle cell disease have abnormal red blood cells that can lead to vessel fragility and increase the risk of Hyphema.
Associated activity
Acuity of presentation
Acuity of Presentation:
Unimpaired Vision: A few people with Hyphema might exhibit unimpaired vision, particularly if the bleeding is insignificant or has resolved prior to the assessment.
Impaired Vision: Most individuals with Hyphema go through a decline in visual acuity because of the existence of blood blocking the visual pathway. The degree of visual impairment relies upon the quantity of blood and its distribution in the anterior chamber.
Hand Motion: In severe cases of Hyphema, where a substantial amount of blood fills the anterior chamber, individuals may have reduced visual acuity to the point where they can only perceive hand motion or count fingers when they are held close to their face.
Differential Diagnoses
DIFFERENTIAL DIAGNOSIS
Neovascularization: Conditions such as diabetic retinopathy or retinal vein occlusion can lead to abnormal blood vessel growth and subsequent Hyphema.
Ocular Tumors: Intraocular tumors, in as uveal melanoma or retinoblastoma, can cause bleeding into the anterior chamber.
Vascular Anomalies: Abnormalities in ocular blood vessels, such as iris vascular malformations or juvenile xanthogranuloma, can result in Hyphema.
Coagulopathies: Bleeding disorders, including hemophilia or von Willebrand disease, may lead to spontaneous Hyphema
Disorders of Ocular Vascular: Various conditions that impact the blood vessels of the eye, such as neovascular glaucoma, central retinal vein occlusion, or proliferative diabetic retinopathy, have the potential to cause intraocular bleeding and Hyphema.
Tumors in the Anterior Chamber: In uncommon cases, tumors situated in the anterior chamber, like iris melanoma or iris cysts, may show bleeding and mimic Hyphema.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
TREATMENT PARADIGM
Modification of Environment:
Modifying the environment for a patient with Hyphema involves creating a safe and conducive setting that promotes the healing and recovery of the eye.
Protection for the Eyes: Recommend the patient to utilize protective gear for their eyes, like goggles or a shield, to avoid any unintentional harm or additional damage to the affected eye.
Rest Activities: Motivate the patient to rest and reduce any activities that may lead to an increase in intraocular pressure or may cause harm to the eye.
Head Elevation: Propose elevating the head using pillows or an adjustable bed while sleeping to keep the head in an elevated position.
Administration of Pharmaceutical Agents with Drugs:
The administration of pharmaceutical agents for Hyphema aims to manage pain, control inflammation, prevent complications, and promote the healing of the eye.
Cycloplegics: Agents with cycloplegic properties, like atropine or cyclopentolate, are administered to enlarge the pupil and alleviate discomfort due to spasms in the ciliary muscle.
Topical Steroids: Eye drops containing corticosteroids are prescribed topically, such as prednisolone, to lessen inflammation and decrease the possibility of secondary complications, such as uveitis following trauma.
Topical Antibiotics: To prevent infections, particularly if there is a corneal injury or risk factors such as contact lens use, ointments or eye drops with antibiotic properties are prescribed topically.
Intervention with a Procedure:
In some cases, interventions with procedures may be required to manage Hyphema, particularly when conservative measures and medical therapies are insufficient.
Initial treatment may include resting in bed with the head elevated to encourage blood to settle at the base of the anterior chamber, reducing the risk of vision obstruction.
Anterior Chamber Washout (ACW) is a surgical procedure that involves removing blood from the anterior chamber to improve visual acuity, relieve increased intraocular pressure, and lower the risk of complications such as corneal blood staining or rebleeding.
Surgical Iridectomy or Iridotomy are procedures that involve creating an opening in the iris to allow blood to drain from the anterior chamber, reducing intraocular pressure and preventing pupillary block.
Phase of Management:
The management of Hyphema involves different phases of care, which aim to address the immediate concerns, prevent complications, and promote healing.
Acute Treatment: During this stage, the main objective is to conduct a primary assessment and take prompt actions to control bleeding and ensure the patient’s well-being. Evaluating the extent of hyphema and accompanying harm. Dispensing analgesics for pain relief. Initiating anti-inflammatory treatment to alleviate swelling and forestall any further complications.
Observation and Conservative Management: After the acute phase, the patient is typically placed on observation and conservative management. Monitoring the progress of Hyphema and assessing visual acuity regularly. Managing pain, inflammation, and IOP as necessary. Providing appropriate activity restrictions, including avoiding activities that may increase IOP or risk further trauma to the eye.
Hyphema is a health condition defined by the presence of blood in the front chamber of the eye, known as the area between the clear front part of the eye (cornea) and the colored part of the eye (iris). Usually, it is triggered by damage or harm to the eye, though it may also be linked to specific hidden medical disorders.
When the eye experiences a blunt or penetrating injury, blood vessels in the iris or other parts of the eye may rupture, leading to bleeding into the anterior chamber. The severity of hyphema can vary, ranging from a small amount of blood that partially fills the chamber to a complete filling of blood, obstructing vision.
The epidemiology of Hyphema:
Incidence and Prevalence: Hyphema is a rare condition, but it can happen among diverse demographics and age brackets. The occurrence and frequency of Hyphema fluctuate based on variables like geographical location, age, and the existence of risk factors. The documented incidence rates 12 out of 100 000, with 70% occurring in children.
Age and Sex: Hyphema can occur at any age, but it is more frequently observed in certain age groups. In children and adolescents, Hyphema commonly occurs due to sports-related injuries. Males are more commonly affected by Hyphema than females, particularly in younger age groups.
Geographical distribution: There may be variations in the incidence and prevalence of Hyphema across different regions or populations. Research indicates that urban settings have a higher prevalence of Hyphema than rural areas, which may be attributed to greater engagement in activities that pose a risk of eye injury.
The pathophysiology of Hyphema involves the disruption of blood vessels within the eye, leading to bleeding into the anterior chamber.
Trauma or injury: Hyphema is frequently caused by vascular damage to the eye. The iris, ciliary body, or other areas of the eye may suffer damage to their blood vessels as a result of blunt or penetrating trauma.
Blood accumulation: When blood flows into the front part of the eye, it builds up and occupies the area between the cornea and iris. The buildup of blood can range from a thin layer to entirely blocking eyesight, depending on the amount of bleeding.
Disruption of normal ocular structures: The presence of blood in the anterior chamber can disrupt normal ocular structures and physiological processes. The blood may interfere with the passage of light, leading to blurred or decreased vision.
Vascular rupture: The damage to the eye’s anterior segment results in the rupture of blood vessels, causing blood to spill into the anterior chamber. The severity of the bleeding is determined by the extent and intensity of the injury.
Trauma: Trauma to the eye is the most common cause of Hyphema. It can result from various activities or accidents such as sports-related injuries, automobile accidents, falls, or physical assaults.
Tumors or Vascular Abnormalities: Hyphema can be associated with ocular tumors or vascular abnormalities. Conditions such as iris melanoma or vascular malformations may present with Hyphema.
Ocular Surgeries: In certain instances, Hyphema may arise as a complication of surgical interventions or procedures related to the eyes. Such interventions may encompass intraocular surgeries such as cataract surgery, glaucoma surgery, or refractive surgery.
The key prognostic factors in Hyphema as follows:
Size and extent: The magnitude and range of blood in the front chamber are crucial predictive factors. Larger Hyphema, where the front chamber is more broadly filled with blood, may carry a greater risk of complications and inferior results compared to smaller Hyphema.
Timing of treatment: The time elapsed between the occurrence of trauma and presentation for medical evaluation can influence prognosis.
Intraocular pressure (IOP) elevation:Elevated intraocular pressure following Hyphema can lead to a condition called Hyphema-induced glaucoma.
Rebleeding: Recurrence of bleeding in the front part of the eye after the first occurrence of Hyphema is known as rebleeding. This can raise the chances of complications and may suggest more serious underlying harm or continuous trauma.
CLINICAL HISTORY
Age Group: Hyphema can occur at any age, but the age group most affected by Hyphema varies based on the underlying cause.
Pediatric age group: Hyphema is a commonly observed condition in children and teenagers, which is often caused by injuries sustained during sports activities. Sports like basketball, soccer, baseball, martial arts, or any other sport that may result in eye trauma can cause Hyphema.
Young Adults: Young adults who engage in sports, high-risk occupations, or activities with potential eye injuries are also at an increased risk of Hyphema.
PHYSICAL EXAMINATION
External Examination: Inspect the external structures of the eye for any signs of trauma, such as eyelid lacerations, swelling, or bruising.
Evaluation and magnitude of Hyphema: Evaluate the quantity of blood in the front part of the eye. It could vary from a slight accumulation at the base to a complete filling of the chamber.
Dilated Fundus Examination: Perform a dilated fundus examination to evaluate the posterior segment of the eye, including the optic nerve, retina, and macula.
Coagulation occurrence: Monitor the presence of blood clots in the Hyphema that might need additional treatment.
Iridodialysis or angle recession: Inspect for any indications of harm to the iris or angle, which can happen in severe injury cases.
Associated Comorbidity or Activity:
Some of the commonly observed comorbidities in Hyphema include:
Ocular Conditions: Bleeding in the eye can result in elevated pressure inside the eye, which could trigger or exacerbate glaucoma in certain situations. Those who already have glaucoma may have an increased likelihood of experiencing bleeding in the eye due to weakened blood flow and delicate vessels.
Specific conditions affecting the retina, like diabetic retinopathy or retinal detachment, may heighten the possibility of bleeding in the front part of the eye and consequent eye bleeding.
Systemic Conditions: Uncontrolled high blood pressure can weaken blood vessels in the eye, making them more susceptible to rupture and bleeding. Individuals with sickle cell disease have abnormal red blood cells that can lead to vessel fragility and increase the risk of Hyphema.
Acuity of Presentation:
Unimpaired Vision: A few people with Hyphema might exhibit unimpaired vision, particularly if the bleeding is insignificant or has resolved prior to the assessment.
Impaired Vision: Most individuals with Hyphema go through a decline in visual acuity because of the existence of blood blocking the visual pathway. The degree of visual impairment relies upon the quantity of blood and its distribution in the anterior chamber.
Hand Motion: In severe cases of Hyphema, where a substantial amount of blood fills the anterior chamber, individuals may have reduced visual acuity to the point where they can only perceive hand motion or count fingers when they are held close to their face.
DIFFERENTIAL DIAGNOSIS
Neovascularization: Conditions such as diabetic retinopathy or retinal vein occlusion can lead to abnormal blood vessel growth and subsequent Hyphema.
Ocular Tumors: Intraocular tumors, in as uveal melanoma or retinoblastoma, can cause bleeding into the anterior chamber.
Vascular Anomalies: Abnormalities in ocular blood vessels, such as iris vascular malformations or juvenile xanthogranuloma, can result in Hyphema.
Coagulopathies: Bleeding disorders, including hemophilia or von Willebrand disease, may lead to spontaneous Hyphema
Disorders of Ocular Vascular: Various conditions that impact the blood vessels of the eye, such as neovascular glaucoma, central retinal vein occlusion, or proliferative diabetic retinopathy, have the potential to cause intraocular bleeding and Hyphema.
Tumors in the Anterior Chamber: In uncommon cases, tumors situated in the anterior chamber, like iris melanoma or iris cysts, may show bleeding and mimic Hyphema.
TREATMENT PARADIGM
Modification of Environment:
Modifying the environment for a patient with Hyphema involves creating a safe and conducive setting that promotes the healing and recovery of the eye.
Protection for the Eyes: Recommend the patient to utilize protective gear for their eyes, like goggles or a shield, to avoid any unintentional harm or additional damage to the affected eye.
Rest Activities: Motivate the patient to rest and reduce any activities that may lead to an increase in intraocular pressure or may cause harm to the eye.
Head Elevation: Propose elevating the head using pillows or an adjustable bed while sleeping to keep the head in an elevated position.
Administration of Pharmaceutical Agents with Drugs:
The administration of pharmaceutical agents for Hyphema aims to manage pain, control inflammation, prevent complications, and promote the healing of the eye.
Cycloplegics: Agents with cycloplegic properties, like atropine or cyclopentolate, are administered to enlarge the pupil and alleviate discomfort due to spasms in the ciliary muscle.
Topical Steroids: Eye drops containing corticosteroids are prescribed topically, such as prednisolone, to lessen inflammation and decrease the possibility of secondary complications, such as uveitis following trauma.
Topical Antibiotics: To prevent infections, particularly if there is a corneal injury or risk factors such as contact lens use, ointments or eye drops with antibiotic properties are prescribed topically.
Intervention with a Procedure:
In some cases, interventions with procedures may be required to manage Hyphema, particularly when conservative measures and medical therapies are insufficient.
Initial treatment may include resting in bed with the head elevated to encourage blood to settle at the base of the anterior chamber, reducing the risk of vision obstruction.
Anterior Chamber Washout (ACW) is a surgical procedure that involves removing blood from the anterior chamber to improve visual acuity, relieve increased intraocular pressure, and lower the risk of complications such as corneal blood staining or rebleeding.
Surgical Iridectomy or Iridotomy are procedures that involve creating an opening in the iris to allow blood to drain from the anterior chamber, reducing intraocular pressure and preventing pupillary block.
Phase of Management:
The management of Hyphema involves different phases of care, which aim to address the immediate concerns, prevent complications, and promote healing.
Acute Treatment: During this stage, the main objective is to conduct a primary assessment and take prompt actions to control bleeding and ensure the patient’s well-being. Evaluating the extent of hyphema and accompanying harm. Dispensing analgesics for pain relief. Initiating anti-inflammatory treatment to alleviate swelling and forestall any further complications.
Observation and Conservative Management: After the acute phase, the patient is typically placed on observation and conservative management. Monitoring the progress of Hyphema and assessing visual acuity regularly. Managing pain, inflammation, and IOP as necessary. Providing appropriate activity restrictions, including avoiding activities that may increase IOP or risk further trauma to the eye.
Hyphema – StatPearls – NCBI Bookshelf (nih.gov)
medtigo
Hyphema
Updated :
January 25, 2024
Hyphema is a health condition defined by the presence of blood in the front chamber of the eye, known as the area between the clear front part of the eye (cornea) and the colored part of the eye (iris). Usually, it is triggered by damage or harm to the eye, though it may also be linked to specific hidden medical disorders.
When the eye experiences a blunt or penetrating injury, blood vessels in the iris or other parts of the eye may rupture, leading to bleeding into the anterior chamber. The severity of hyphema can vary, ranging from a small amount of blood that partially fills the chamber to a complete filling of blood, obstructing vision.
The epidemiology of Hyphema:
Incidence and Prevalence: Hyphema is a rare condition, but it can happen among diverse demographics and age brackets. The occurrence and frequency of Hyphema fluctuate based on variables like geographical location, age, and the existence of risk factors. The documented incidence rates 12 out of 100 000, with 70% occurring in children.
Age and Sex: Hyphema can occur at any age, but it is more frequently observed in certain age groups. In children and adolescents, Hyphema commonly occurs due to sports-related injuries. Males are more commonly affected by Hyphema than females, particularly in younger age groups.
Geographical distribution: There may be variations in the incidence and prevalence of Hyphema across different regions or populations. Research indicates that urban settings have a higher prevalence of Hyphema than rural areas, which may be attributed to greater engagement in activities that pose a risk of eye injury.
The pathophysiology of Hyphema involves the disruption of blood vessels within the eye, leading to bleeding into the anterior chamber.
Trauma or injury: Hyphema is frequently caused by vascular damage to the eye. The iris, ciliary body, or other areas of the eye may suffer damage to their blood vessels as a result of blunt or penetrating trauma.
Blood accumulation: When blood flows into the front part of the eye, it builds up and occupies the area between the cornea and iris. The buildup of blood can range from a thin layer to entirely blocking eyesight, depending on the amount of bleeding.
Disruption of normal ocular structures: The presence of blood in the anterior chamber can disrupt normal ocular structures and physiological processes. The blood may interfere with the passage of light, leading to blurred or decreased vision.
Vascular rupture: The damage to the eye’s anterior segment results in the rupture of blood vessels, causing blood to spill into the anterior chamber. The severity of the bleeding is determined by the extent and intensity of the injury.
Trauma: Trauma to the eye is the most common cause of Hyphema. It can result from various activities or accidents such as sports-related injuries, automobile accidents, falls, or physical assaults.
Tumors or Vascular Abnormalities: Hyphema can be associated with ocular tumors or vascular abnormalities. Conditions such as iris melanoma or vascular malformations may present with Hyphema.
Ocular Surgeries: In certain instances, Hyphema may arise as a complication of surgical interventions or procedures related to the eyes. Such interventions may encompass intraocular surgeries such as cataract surgery, glaucoma surgery, or refractive surgery.
The key prognostic factors in Hyphema as follows:
Size and extent: The magnitude and range of blood in the front chamber are crucial predictive factors. Larger Hyphema, where the front chamber is more broadly filled with blood, may carry a greater risk of complications and inferior results compared to smaller Hyphema.
Timing of treatment: The time elapsed between the occurrence of trauma and presentation for medical evaluation can influence prognosis.
Intraocular pressure (IOP) elevation:Elevated intraocular pressure following Hyphema can lead to a condition called Hyphema-induced glaucoma.
Rebleeding: Recurrence of bleeding in the front part of the eye after the first occurrence of Hyphema is known as rebleeding. This can raise the chances of complications and may suggest more serious underlying harm or continuous trauma.
CLINICAL HISTORY
Age Group: Hyphema can occur at any age, but the age group most affected by Hyphema varies based on the underlying cause.
Pediatric age group: Hyphema is a commonly observed condition in children and teenagers, which is often caused by injuries sustained during sports activities. Sports like basketball, soccer, baseball, martial arts, or any other sport that may result in eye trauma can cause Hyphema.
Young Adults: Young adults who engage in sports, high-risk occupations, or activities with potential eye injuries are also at an increased risk of Hyphema.
PHYSICAL EXAMINATION
External Examination: Inspect the external structures of the eye for any signs of trauma, such as eyelid lacerations, swelling, or bruising.
Evaluation and magnitude of Hyphema: Evaluate the quantity of blood in the front part of the eye. It could vary from a slight accumulation at the base to a complete filling of the chamber.
Dilated Fundus Examination: Perform a dilated fundus examination to evaluate the posterior segment of the eye, including the optic nerve, retina, and macula.
Coagulation occurrence: Monitor the presence of blood clots in the Hyphema that might need additional treatment.
Iridodialysis or angle recession: Inspect for any indications of harm to the iris or angle, which can happen in severe injury cases.
Associated Comorbidity or Activity:
Some of the commonly observed comorbidities in Hyphema include:
Ocular Conditions: Bleeding in the eye can result in elevated pressure inside the eye, which could trigger or exacerbate glaucoma in certain situations. Those who already have glaucoma may have an increased likelihood of experiencing bleeding in the eye due to weakened blood flow and delicate vessels.
Specific conditions affecting the retina, like diabetic retinopathy or retinal detachment, may heighten the possibility of bleeding in the front part of the eye and consequent eye bleeding.
Systemic Conditions: Uncontrolled high blood pressure can weaken blood vessels in the eye, making them more susceptible to rupture and bleeding. Individuals with sickle cell disease have abnormal red blood cells that can lead to vessel fragility and increase the risk of Hyphema.
Acuity of Presentation:
Unimpaired Vision: A few people with Hyphema might exhibit unimpaired vision, particularly if the bleeding is insignificant or has resolved prior to the assessment.
Impaired Vision: Most individuals with Hyphema go through a decline in visual acuity because of the existence of blood blocking the visual pathway. The degree of visual impairment relies upon the quantity of blood and its distribution in the anterior chamber.
Hand Motion: In severe cases of Hyphema, where a substantial amount of blood fills the anterior chamber, individuals may have reduced visual acuity to the point where they can only perceive hand motion or count fingers when they are held close to their face.
DIFFERENTIAL DIAGNOSIS
Neovascularization: Conditions such as diabetic retinopathy or retinal vein occlusion can lead to abnormal blood vessel growth and subsequent Hyphema.
Ocular Tumors: Intraocular tumors, in as uveal melanoma or retinoblastoma, can cause bleeding into the anterior chamber.
Vascular Anomalies: Abnormalities in ocular blood vessels, such as iris vascular malformations or juvenile xanthogranuloma, can result in Hyphema.
Coagulopathies: Bleeding disorders, including hemophilia or von Willebrand disease, may lead to spontaneous Hyphema
Disorders of Ocular Vascular: Various conditions that impact the blood vessels of the eye, such as neovascular glaucoma, central retinal vein occlusion, or proliferative diabetic retinopathy, have the potential to cause intraocular bleeding and Hyphema.
Tumors in the Anterior Chamber: In uncommon cases, tumors situated in the anterior chamber, like iris melanoma or iris cysts, may show bleeding and mimic Hyphema.
TREATMENT PARADIGM
Modification of Environment:
Modifying the environment for a patient with Hyphema involves creating a safe and conducive setting that promotes the healing and recovery of the eye.
Protection for the Eyes: Recommend the patient to utilize protective gear for their eyes, like goggles or a shield, to avoid any unintentional harm or additional damage to the affected eye.
Rest Activities: Motivate the patient to rest and reduce any activities that may lead to an increase in intraocular pressure or may cause harm to the eye.
Head Elevation: Propose elevating the head using pillows or an adjustable bed while sleeping to keep the head in an elevated position.
Administration of Pharmaceutical Agents with Drugs:
The administration of pharmaceutical agents for Hyphema aims to manage pain, control inflammation, prevent complications, and promote the healing of the eye.
Cycloplegics: Agents with cycloplegic properties, like atropine or cyclopentolate, are administered to enlarge the pupil and alleviate discomfort due to spasms in the ciliary muscle.
Topical Steroids: Eye drops containing corticosteroids are prescribed topically, such as prednisolone, to lessen inflammation and decrease the possibility of secondary complications, such as uveitis following trauma.
Topical Antibiotics: To prevent infections, particularly if there is a corneal injury or risk factors such as contact lens use, ointments or eye drops with antibiotic properties are prescribed topically.
Intervention with a Procedure:
In some cases, interventions with procedures may be required to manage Hyphema, particularly when conservative measures and medical therapies are insufficient.
Initial treatment may include resting in bed with the head elevated to encourage blood to settle at the base of the anterior chamber, reducing the risk of vision obstruction.
Anterior Chamber Washout (ACW) is a surgical procedure that involves removing blood from the anterior chamber to improve visual acuity, relieve increased intraocular pressure, and lower the risk of complications such as corneal blood staining or rebleeding.
Surgical Iridectomy or Iridotomy are procedures that involve creating an opening in the iris to allow blood to drain from the anterior chamber, reducing intraocular pressure and preventing pupillary block.
Phase of Management:
The management of Hyphema involves different phases of care, which aim to address the immediate concerns, prevent complications, and promote healing.
Acute Treatment: During this stage, the main objective is to conduct a primary assessment and take prompt actions to control bleeding and ensure the patient’s well-being. Evaluating the extent of hyphema and accompanying harm. Dispensing analgesics for pain relief. Initiating anti-inflammatory treatment to alleviate swelling and forestall any further complications.
Observation and Conservative Management: After the acute phase, the patient is typically placed on observation and conservative management. Monitoring the progress of Hyphema and assessing visual acuity regularly. Managing pain, inflammation, and IOP as necessary. Providing appropriate activity restrictions, including avoiding activities that may increase IOP or risk further trauma to the eye.
Hyphema – StatPearls – NCBI Bookshelf (nih.gov)
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
